News
FDA approves blood test to detect Alzheimer’s disease
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by Fujirebio Diagnostics, is simple: Early detection of beta-amyloid plaques linked to the neurocognitive disease in adults 55 and older who are exhibiting signs and symptoms of the disorder.
Burruss’ aunt is part of the beloved “Old Lady Gang.” In addition to Jones, the trio — which earned the nickname "Old Lady ...
Alzheimer’s is the seventh-leading cause of death among US adults, with the average patient living four to eight years after diagnosis.
M ore than 7 million Americans have Alzheimer’s Disease, according to the Alzheimer’s Association. And one in nine people ...
A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...
Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...
In a statement posted by the Massachusetts Institute of Technology Monday, researchers said they have used data about fruit ...
15hon MSN
Alzheimer’s is a complex disease caused by many interacting factors. It’s possible the herpes virus could play a small role – ...
Thousands of people have paid for Dale Bredesen’s unconventional program to reverse Alzheimer’s symptoms. Experts aren't so ...
Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's disease (AD) and other conditions that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback